Allan Cortes
We help biotech companies bridge the gap from preclinical to clinical by providing rapid bioanalytical, biomarker, and immunogenicity development to bring life changing therapies to patients.
- Role
- Director, Business Development (Bioanalysis) at Celerion
- Location
- San Diego, CA, US
- LinkedIn followers
- 500 followers
About Allan Cortes
Currently a Director, Business Development (Bioanalysis) at Crystal Bio, a…
Experience
Director, Business Development (Bioanalysis)
Jan 2025 — Present
As Director of Business Development for Bioanalysis & Biomarkers, I lead strategic engagement with biotech and pharmaceutical companies to accelerate early-stage drug development. My role focuses on delivering tailored solutions that bridge preclinical and clinical phases through Celerion’s world-class bioanalytical and biomarker services. Partner with IND-stage and emerging biotech companies to align bioanalytical strategy with clinical development timelines. Represent Celerion’s GLP/CLIA-certified capabilities in PK, ADA, NAb, biomarker, and metabolite ID assay development and validation. Guide clients through early development decisions, supporting seamless transitions from preclinical studies to FIH trials. Drive strategic outreach, pipeline engagement, and long-term partnerships across the Western U.S.Collaborate with internal scientific, operational, and regulatory teams to ensure delivery of high-quality, compliant data packages. Stay ahead of industry trends in molecular platforms, gene/cell therapies, and novel biomarkers to align services with sponsor needs.
Education
UC San Diego
Bachelor of Science - BS, Nanoengineering
2010 — 2015
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.